(IYH) U.S. Healthcare - Overview
ETF Category: Health | Exchange: NYSE (USA) | Market Cap: 3.118m USD | Total Return: 15.8% in 12m
Avg Turnover: 32.7M
Warnings
Extended 3d
Tailwinds
No distinct edge detected
The iShares U.S. Healthcare ETF (IYH) tracks the performance of the U.S. healthcare sector by investing at least 80% of its assets in its underlying index. Launched in 2000, the fund is non-diversified and provides concentrated exposure to domestic pharmaceutical, biotechnology, and medical device companies.
The healthcare sector typically operates on a defensive business model, as demand for medical services and life-saving drugs remains relatively inelastic during economic downturns. Companies in this space often face high research and development costs balanced by long-term patent protections on proprietary products.
Investors can further analyze these underlying holdings and valuation metrics on ValueRay. Given its mid-cap status and sector-specific focus, the fund remains sensitive to federal healthcare policy changes and regulatory approval cycles for new treatments.
- Medicare drug price negotiations impact pharmaceutical and biotech profit margins
- FDA approval cycles and R&D pipelines drive biotechnology segment valuation
- Aging US demographics sustain long-term demand for healthcare services and equipment
- Federal healthcare policy and insurance reimbursement rates influence provider profitability
As of June 08, 2026, the stock is trading at USD 64.24 with a total of 6,030,397 shares traded.
Over the past week, the price has changed by +1.92%,
over one month by +5.40%,
over three months by -0.02% and
over the past year by +15.76%.
U.S. Healthcare has no consensus analysts rating.